Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
People who switched showed improvement in markers of kidney and bone health but also rise in lipid levels.
Liver complications, heart disease and non-liver cancers also account for most deaths among people with hepatitis B or C.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
290 million people have viral hepatitis and don’t know it. Raise awareness with a virtual video relay.
Most vaccines can be administered on a flexible timeline if the originally recommended timeline is missed.
Researchers have challenged findings from a Chinese study that concluded Baraclude is tied to a lower risk of liver cancer.
New research shows that treating these viruses can reduce liver cancer risk.
Available vaccines offer protection against cervical, anal, oral, liver and stomach cancers.
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
This finding may reflect higher rates of sexually transmitted infections such as HPV and hep B as well as lifestyle factors.
The LIVER Act would increase funding for liver cancer and hepatitis B research and prevention.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
People who receive chemotherapy for cancer have a higher risk of hep B reactivation.
Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.
Women with a history of the malignancy also survive longer than men after receiving a liver transplant.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.